Group 1 - The company conducted significant share buybacks on December 11 and 12, totaling nearly 200 million HKD, reflecting management's long-term confidence in the company's value and future growth [1] - On December 11, the company repurchased 8.14 million shares at an average price of 12.26 HKD per share, costing 99.77 million HKD, and on December 12, it repurchased 7.99 million shares at an average price of 12.48 HKD per share, costing 99.76 million HKD [1] - The proportion of shares held by the trustee increased from 1.2853% to 1.5457% following these buybacks [1] Group 2 - In Q3 2025, the company's revenue reached approximately 4.197 billion RMB, a year-on-year increase of 27.2%, driven by the successful launch of heated non-combustible (HNB) products in major global markets [1] - The company benefited from stricter global regulations leading to the elimination of non-compliant products, positioning itself as a compliant leader in the industry [1] - Adjusted net profit for Q3 was approximately 444 million RMB, reflecting a year-on-year growth of 4.0%, with effective cost control as the growth rate of expenses was lower than that of revenue [1] Group 3 - The company is recognized as a global leader in electronic vaporization, focusing on R&D and technological leadership [2] - Future revenue projections for the company are 14.108 billion RMB, 16.717 billion RMB, and 19.867 billion RMB for 2025-2027, with year-on-year growth rates of 19.57%, 18.50%, and 18.84% respectively [2] - Net profit forecasts for the same period are 1.043 billion RMB, 1.931 billion RMB, and 2.726 billion RMB, with growth rates of -19.93%, 85.12%, and 41.14% respectively [2]

Investment Rating - The investment rating for Smoore International is maintained as "Buy-A" with a target price of HKD 16.80 [6][4]. Core Insights - Smoore International has demonstrated strong confidence in its long-term value through significant share buybacks, totaling nearly HKD 200 million over two days [2]. - The company reported record revenue of approximately RMB 4.197 billion for Q3 2025, reflecting a year-on-year growth of 27.2%, driven by the successful launch of new heated not-burn (HNB) products in major global markets [3]. - The company is positioned to benefit from stricter global regulations on non-compliant products, enhancing its status as a compliant leader in the industry [4]. Financial Summary - Revenue projections for Smoore International from 2025 to 2027 are RMB 141.08 billion, RMB 167.17 billion, and RMB 198.67 billion, representing year-on-year growth rates of 19.57%, 18.50%, and 18.84% respectively [4]. - Net profit estimates for the same period are RMB 10.43 billion, RMB 19.31 billion, and RMB 27.26 billion, with growth rates of -19.93%, 85.12%, and 41.14% respectively [4]. - The company’s price-to-earnings (PE) ratios are projected to be 63.16x, 34.12x, and 24.17x for 2025, 2026, and 2027 respectively [4].

Group 1 - The core viewpoint of the report is that Smoore International (06969) maintains a "Buy" investment rating due to its leadership in the global electronic vaporization market, ongoing R&D efforts, and strong management confidence reflected in recent share buybacks [1] - The company has conducted significant share repurchases, spending nearly HKD 200 million over two days, which indicates long-term confidence from management regarding the company's value and future business growth [1] - The projected revenue for Smoore International from 2025 to 2027 is estimated to be RMB 14.108 billion, RMB 16.717 billion, and RMB 19.867 billion, representing year-on-year growth rates of 19.57%, 18.50%, and 18.84% respectively [1] Group 2 - In Q3 2025, the company achieved record revenue of approximately RMB 4.197 billion, a year-on-year increase of 27.2%, primarily driven by the successful launch of heated not-burn (HNB) products by strategic clients in major global markets [2] - The tightening of global regulations has accelerated the exit of non-compliant products, allowing the company, as a compliant leader, to fully benefit from policy advantages, resulting in steady growth in its electronic vaporization business [2] - The adjusted net profit for Q3 was approximately RMB 444 million, reflecting a year-on-year growth of 4.0%, with excellent cost control as the growth rate of expenses was lower than that of revenue [2]

Core Viewpoint - Guotou Securities maintains a "Buy" rating for Smoore International (06969), highlighting its leadership in the global electronic vaporization market and its commitment to R&D and technology innovation. The company is expected to benefit from increased regulatory scrutiny on non-compliant products and ongoing business expansion, with significant share buybacks reflecting long-term confidence in its growth potential [1][8]. Group 1: Share Buybacks - The company executed two significant share buybacks on December 11 and 12, spending nearly HKD 200 million. On December 11, it repurchased 8.14 million shares at an average price of HKD 12.26 per share, costing HKD 99.77 million. On December 12, it repurchased 7.99 million shares at an average price of HKD 12.48 per share, costing HKD 99.76 million. The proportion of shares held by the trustee increased from 1.2853% to 1.5457%, indicating management's long-term confidence in the company's value and future growth [2][8]. Group 2: Financial Performance - In Q3 2025, the company achieved a record revenue of approximately RMB 4.197 billion, representing a year-on-year growth of 27.2%. This strong performance was primarily driven by the successful launch of heated not-burn (HNB) products by strategic clients in major global markets. The tightening global regulations accelerated the exit of non-compliant products, allowing the company to fully benefit from policy advantages as a compliant leader. The flagship new products contributed to an increase in the share of its proprietary brand business. Adjusted net profit for Q3 was approximately RMB 444 million, up 4.0% year-on-year, with expense growth below revenue growth, indicating excellent cost control [3][9]. Group 3: Revenue Projections - Guotou Securities projects Smoore International's revenue for 2025-2027 to be RMB 14.108 billion, RMB 16.717 billion, and RMB 19.867 billion, reflecting year-on-year growth rates of 19.57%, 18.50%, and 18.84% respectively. The company is assigned a target price of HKD 16.80 for 2026, based on a price-to-earnings ratio of 48x [1][8].

Group 1 - The company, Dimi Life Holdings, is optimistic about the prospects of the electronic vaporization and medical beauty vaporization industries and plans to leverage its technology R&D and supply chain management advantages in these sectors [1] - A strategic cooperation framework agreement was signed on January 8, 2026, between Dimi Chain Technology Co., Ltd. and its partners, making Dimi Chain the main raw material supplier in China during the agreement's duration [1] - The board of directors is seeking diversification opportunities due to the downturn in the Hong Kong and Chinese construction and real estate industries, believing that technology related to daily life will be the next trend [1] Group 2 - The electronic vaporization industry is in a stable growth phase, with increasing regulatory policies globally aimed at youth protection, environmental protection, product safety, and taxation [2] - The board has decided to gradually enter the electronic vaporization industry by providing raw material supply and technical cooperation, utilizing resources and experience gained from the electric toothbrush business [2] - The company is actively seeking professionals in the electronic vaporization industry to assist in developing this new business [2]

Core Viewpoint - Smoore International (06969) has seen a stock increase of over 4%, currently trading at HKD 12.96, with a transaction volume of HKD 146 million. The company has renewed its procurement framework agreement with EVE Energy, effective from January 2026 to December 2028, for battery products, indicating a positive outlook for the electronic vaporization product market [1]. Group 1 - The renewed procurement agreement with EVE Energy is expected to support the continuous growth of Smoore's product orders due to the expanding global electronic vaporization market [1]. - The company is likely to benefit from the entry of major international tobacco players' heated non-combustible (HNB) products into mainstream markets, which may contribute to sales growth in new regions [1]. - In Europe, particularly in the UK, there is potential for a shift towards more profitable pod-based and open-system products, enhancing profitability [1]. Group 2 - The enforcement of electronic cigarette regulations in the United States is expected to restore market share for compliant products, providing significant recovery opportunities [1]. - Smoore's diverse business segments, including vapor electronic cigarettes, HNB, vapor beauty, and vapor medical products, are entering a harvest phase, with global launches and multi-point catalysts anticipated [1].

Core Viewpoint - The report from Guotai Junan indicates that Smoore International (06969) has shown an upward trend in industry prosperity in Q3, leading to an upward revision of profit forecasts for the company, with expected net profits of 1.03 billion, 1.94 billion, and 2.54 billion yuan for 2025-2027, maintaining a "Buy" rating [1] Group 1: Financial Performance - In Q3 2025, the company achieved a record revenue of 4.197 billion yuan, a year-on-year increase of 27.2% and a quarter-on-quarter increase of 27.5% [1] - The net profit attributable to shareholders was 317 million yuan, a year-on-year decrease of 16.4% but a quarter-on-quarter increase of 5.7%; excluding stock incentive expenses, net profit increased by 4.0% year-on-year and 4.8% quarter-on-quarter [1] Group 2: Business Growth - The OEM and proprietary brand revenues both experienced growth on a quarter-on-quarter basis, with significant increases in HNB and vaping businesses [2] - In the HNB segment, the company supported strategic customers in global market expansion, resulting in a substantial increase in product shipments [2] - In the vaping segment, the company assisted more clients in launching new compliant electronic vaping products due to increased regulatory scrutiny in major global markets [2] Group 3: Industry Outlook - The traditional vaping business is expected to benefit from changes in regulatory environments in the US and Europe, with a potential increase in market share under compliant operations [3] - The new Glo Hilo product in the HNB segment has received positive feedback, with the company aiding clients in nationwide product promotion in Japan by September 2025 and plans to expand into more core markets in the second half of 2025 [3] - The company has developed multiple technology platforms to address various user pain points, and collaborative efforts to accelerate commercialization are ongoing, indicating a clear growth path for the business [3]

Core Viewpoint - Smoore International (06969) reported significant revenue growth in Q3 2025, reaching 4.197 billion yuan, a 27.2% year-on-year increase, but faced declining profitability with a net profit of 317 million yuan, down 16.4% year-on-year [1][11] Revenue Performance - The company achieved a record high quarterly revenue, with total revenue for the first three quarters of 2025 at 10.21 billion yuan, up 21.8% year-on-year [1] - Revenue growth was primarily driven by the enterprise client business and proprietary brand business, with overseas markets, particularly Europe and the US, contributing over 97% of revenue [1][5] Profitability Challenges - Despite revenue growth, net profit has declined for four consecutive years, with a net profit margin dropping to 7.92% in the first three quarters of 2025 [1][10] - The gross margin has also decreased from 43.3% in 2022 to 37.3% in the first half of 2025, indicating pressure on profitability [10] Business Segments - The company operates two main business segments: enterprise client business and proprietary brand business, both focusing on overseas markets, especially Europe [5][6] - The enterprise client business generated 2.734 billion yuan in Europe and other countries in the first half of 2025, a 38% increase, accounting for 57.7% of this segment's revenue [5] - The proprietary brand business saw revenue of 1.07 billion yuan in Europe and other countries, a 15.1% increase, contributing 84% of its segment revenue [5] Research and Development - Smoore International has invested heavily in R&D, with total R&D expenditure of 722 million yuan in the first half of 2025, focusing on electronic nicotine delivery systems [7][9] - The company holds a significant number of patents, with 839 new patent applications globally, indicating a strong commitment to innovation [9] Market Outlook - The company has shifted its market strategy post-2022, focusing on overseas expansion to recover from previous declines in revenue [2][11] - Despite challenges in the US and China markets, the company anticipates continued high growth in Europe and other international markets [6][11] Investment Sentiment - Analysts have mixed views on Smoore International, with some predicting revenue growth driven by electronic cigarette sales but cautioning about rising costs and declining net profit [11] - Others remain optimistic about the company's potential for recovery and growth, particularly in the HNB product line [11]

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company has shown rapid revenue growth, with a 21.8% year-on-year increase in total revenue for the first three quarters of 2025, amounting to 10.21 billion yuan [8] - The HNB (Heated Not Burned) products are gradually being promoted, with positive feedback from customers and plans for expansion into new markets [8] - The company is expected to benefit from stricter regulations in the electronic vaporization market, leading to a recovery in its business [8] Financial Summary - Total revenue projections for 2023A, 2024A, 2025E, 2026E, and 2027E are 11,168 million yuan, 11,799 million yuan, 13,722 million yuan, 16,166 million yuan, and 18,395 million yuan respectively, with year-on-year growth rates of -8.04%, 5.64%, 16.30%, 17.81%, and 13.79% [1] - The net profit attributable to the parent company for the same years is projected to be 1,645 million yuan, 1,303 million yuan, 1,331 million yuan, 2,219 million yuan, and 2,893 million yuan, with year-on-year growth rates of -34.47%, -20.78%, 2.11%, 66.75%, and 30.37% [1] - The latest diluted EPS (Earnings Per Share) is forecasted to be 0.27 yuan, 0.21 yuan, 0.21 yuan, 0.36 yuan, and 0.47 yuan for the years 2023A to 2027E [1] Market Data - The closing price of the company's stock is 15.77 HKD, with a market capitalization of approximately 89.18 billion HKD [5] - The price-to-book ratio is 3.97 [5] - The company has a total share capital of 6,193.04 million shares [6]

Group 1: Company Developments - Transpire Bio, a wholly-owned subsidiary of Smoore International, has submitted an Abbreviated New Drug Application (ANDA) for Breo® Ellipta® and received acceptance from the FDA on September 23 [1][1] - If approved, Transpire Bio will have a 180-day exclusivity period in the U.S. market for Breo® Ellipta®, which is used for the maintenance treatment of asthma and COPD, with projected sales of $2.02 billion in 2024 [1][1] - This breakthrough highlights Transpire Bio's strategic positioning in the complex generic drug sector and strengthens Smoore International's innovative advantage in the global inhalation drug market [1][1] Group 2: Industry Trends - The FDA has launched a pilot program to enhance the efficiency of pre-market tobacco product applications (PMTAs) for nicotine pouch products, aiming for more frequent feedback and shorter review times [2][2] - The pilot program reflects the FDA's commitment to improving regulatory efficiency while maintaining scientific standards for tobacco product reviews [2][2] - As of now, the FDA has authorized 20 nicotine pouch products, with potential for more varieties in the future [2][2] Group 3: Export Data - In the first eight months of 2025, the export value of e-cigarettes and similar personal vaporizing devices reached $2.116 billion, a year-on-year increase of 14.55%, while other non-combustible nicotine products saw a decrease of 18.31% [3][3] - In August 2025, the export value of e-cigarettes was $301 million, up 34.01% year-on-year, while other nicotine products reached $635 million, down 5.68% year-on-year [3][3] - The average export price for e-cigarettes was $4.46 per unit, with an overall export price of $45.07 per kilogram in August [3][3] Group 4: Regional Insights - The top five export destinations (U.S., U.K., Germany, South Korea, UAE) accounted for 62.32% of total exports in the first eight months of 2025, a slight decrease of 0.56 percentage points year-on-year [4][4] - The U.S. remains the largest market with an export value of $2.199 billion, down 8.67% year-on-year, representing 33.56% of total exports [4][4] - Notable growth was observed in exports to the UAE and Indonesia, with increases of 60.57% and 67.25% respectively, while South Korea, Russia, and the Netherlands experienced significant declines [4][4]